Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logo brought to you by Benzinga Data
$0.489800
-0.05-9.30%
At close: -
$0.489300
-0.0005-0.10%
After Hours: 5:14 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
Journey Therapeutics, Inc announced it will be merged with Entero Therapeutics (ENTO) on Wednesday, November 13, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Ratings for Entero Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Entero Therapeutics (ENTO) stock?

A

There is no price target for Entero Therapeutics

Q

What is the most recent analyst rating for Entero Therapeutics (ENTO)?

A

There is no analyst for Entero Therapeutics

Q

When was the last upgrade for Entero Therapeutics (ENTO)?

A

There is no last upgrade for Entero Therapeutics

Q

When was the last downgrade for Entero Therapeutics (ENTO)?

A

There is no last downgrade for Entero Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Entero Therapeutics (ENTO)?

A

There is no next analyst rating for Entero Therapeutics.

Q

Is the Analyst Rating Entero Therapeutics (ENTO) correct?

A

There is no next analyst rating for Entero Therapeutics.

Browse analyst ratings and price targets on all stocks.

People Also Watch